What is CMV Retinitis?

Vision is one of our most vital senses, and any condition that puts it at risk can be both physically and emotionally challenging. One such condition is CMV retinitis, a serious eye infection that primarily affects people with weakened immune systems. While it may not be widely known outside of medical circles, understanding this condition is crucial, especially for those at higher risk.

CMV retinitis is an inflammation of the retina caused by cytomegalovirus (CMV), a common virus in the herpesvirus family. While CMV is widespread—most people are exposed to it at some point—it’s usually dormant and causes no symptoms in individuals with healthy immune systems. However, in people with compromised immunity, such as those living with HIV/AIDS, undergoing organ transplants, or receiving chemotherapy, the virus can reactivate and spread to the retina, leading to vision loss.

Who Is at Risk?

CMV retinitis typically affects:

People with advanced HIV/AIDS, especially with CD4 counts below 50 cells/mm³
Organ or bone marrow transplant recipients on immunosuppressive therapy
Cancer patients receiving high-dose chemotherapy
Individuals with congenital CMV infection (passed from mother to baby)

Thanks to the introduction of antiretroviral therapy (ART), the incidence of CMV retinitis has significantly declined among people living with HIV. However, it remains a concern in those who are untreated or unaware of their HIV status.

Symptoms of CMV Retinitis

CMV retinitis often starts in one eye but can progress to both. Symptoms may be subtle at first but can rapidly worsen if left untreated. Common signs include:

Blurred or decreased vision
Floaters (spots or threads in vision)
Blind spots
Flashes of light
Loss of peripheral vision
In severe cases, retinal detachment, leading to sudden and irreversible blindness

Early symptoms may go unnoticed, especially if the infection begins in the peripheral retina. That’s why regular eye exams are essential for high-risk individuals.

How Is CMV Retinitis Diagnosed?

Diagnosis is usually made through a comprehensive eye examination by an ophthalmologist. Techniques used include:

Dilated eye exam: To check for characteristic signs like white or yellow retinal lesions with associated bleeding.
Fundus photography: Captures detailed images of the retina.
Optical Coherence Tomography (OCT): Helps evaluate retinal thickness and damage.
Blood tests or PCR testing may be done to confirm active CMV infection in certain cases.

Treatment Options

While there is no cure for CMV, treatment aims to control the infection, preserve vision, and prevent recurrence. Treatment approaches include:

1. Antiviral Medications

Ganciclovir (intravenous or intraocular implant)
Valganciclovir (oral form)
Foscarnet or Cidofovir for resistant cases

These medications stop the virus from replicating, though they don’t eliminate it entirely.

2. Immune System Support

For individuals with HIV/AIDS, starting or optimizing antiretroviral therapy (ART) can help restore immune function and control CMV.

3. Retinal Detachment Repair

If retinal detachment occurs, surgical intervention may be required to preserve any remaining vision.

Living with CMV Retinitis

Managing CMV retinitis requires a coordinated approach involving:

Regular eye checkups
Strict adherence to medication
Monitoring for side effects of antiviral drugs, which can include bone marrow suppression and kidney damage
Immediate reporting of new symptoms

Some patients may require lifelong maintenance therapy to prevent recurrence if immune recovery isn’t sufficient.

Prevention Tips

While CMV cannot be completely prevented, these steps can reduce the risk of CMV retinitis in high-risk individuals:

Regular screening for HIV-positive patients with low CD4 counts
Early initiation of ART
Avoiding contact with CMV-infected bodily fluids, especially in transplant settings
Good hand hygiene and infection control practices in immunocompromised individuals

Conclusion

CMV retinitis may be rare, but for those at risk, it’s a serious threat that demands awareness and proactive care. Prompt diagnosis and early treatment are key to preserving vision and maintaining quality of life. With advances in antiviral therapies and HIV management, the outlook for people with CMV retinitis has greatly improved—but vigilance remains essential.

The list of some CMV Retinitis medicine:
Letedx